Skip to main content
SpringerLink
Log in

General Dermatology

  • Chapter
  • First Online:
Practical Guide to Dermatology

  • 1358 Accesses

Abstract

In this section, we will cover common diseases encountered in the general dermatology clinic. The approach to many of these entities is similar, including a good history and physical exam and consideration of medical photography (for lesion monitoring over time) followed by diagnostic work-up such as laboratory testing or biopsy . Many entities are treated first with emollients, topical corticosteroids or topical calcineurin inhibitors followed by more systemic treatment approaches such as phototherapy and/or systemic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kutlubay Z, Engin B, Bairamov O, Tuzun Y. Acanthosis nigricans: a fold (intertriginous) dermatosis. Clin Dermatol. 2015;33(4):466–70.

    Article  PubMed  Google Scholar 

  2. Melibary YT. Hidradenitis suppurativa in a patient with hyperandrogenism, insulin-resistance and acanthosis nigricans (HAIR-AN syndrome). Dermatol Rep. 2018;10(1):7546.

    Article  Google Scholar 

  3. Blobstein SH. Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity. Cutis. 2003;71(1):33–4.

    PubMed  Google Scholar 

  4. Adigun CG, Pandya AG. Improvement of idiopathic acanthosis nigricans with a triple combination depigmenting cream. J Eur Acad Dermatol Venereol. 2009;23(4):486–7.

    Article  CAS  PubMed  Google Scholar 

  5. Rosenbach A, Ram R. Treatment of Acanthosis nigricans of the axillae using a long-pulsed (5-msec) alexandrite laser. Dermatol Surg. 2004;30(8):1158–60.

    PubMed  Google Scholar 

  6. Greywal T, Zaenglein AL, Baldwin HE, et al. Evidence-based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol. 2017;77(1):109–17.

    Article  PubMed  Google Scholar 

  7. Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:709152.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Alexiades M. Laser and light-based treatments of acne and acne scarring. Clin Dermatol. 2017;35(2):183–9.

    Article  PubMed  Google Scholar 

  9. Agarwal N, Gupta LK, Khare AK, Kuldeep CM, Mittal A. Therapeutic response of 70% trichloroacetic acid CROSS in atrophic acne scars. Dermatol Surg. 2015;41(5):597–604.

    Article  CAS  PubMed  Google Scholar 

  10. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32.

    Google Scholar 

  11. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–51.

    Google Scholar 

  12. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49.

    Google Scholar 

  13. Beck LA, Thaci D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371(2):130–9.

    Article  PubMed  CAS  Google Scholar 

  14. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130(6):1355–60.

    Article  CAS  PubMed  Google Scholar 

  15. Iorizzo M. Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis. Dermatol Clin. 2015;33(2):175–83.

    Article  CAS  PubMed  Google Scholar 

  16. Saenger AK, Jaffe AS, Body R, et al. Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB). Clin Chem Lab Med. 2018.

    Google Scholar 

  17. Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: a comprehensive review: epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018;79(4):599–614.

    Article  PubMed  Google Scholar 

  18. Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA. Urticaria: a comprehensive review: treatment of chronic urticaria, special populations, and disease outcomes. J Am Acad Dermatol. 2018;79(4):617–33.

    Article  PubMed  Google Scholar 

  19. Sharma M, Bennett C, Carter B, Cohen SN. H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review. J Am Acad Dermatol. 2015;73(4):710–716. e714.

    Google Scholar 

  20. Tonacci A, Billeci L, Pioggia G, Navarra M, Gangemi S. Omalizumab for the treatment of chronic idiopathic urticaria: systematic review of the literature. Pharmacotherapy. 2017;37(4):464–80.

    Article  PubMed  Google Scholar 

  21. Pinto Gouveia M, Gameiro A, Pinho A, Goncalo M. Long-term management of chronic spontaneous urticaria with omalizumab. Clin Exp Dermatol. 2017;42(7):735–42.

    Article  CAS  PubMed  Google Scholar 

  22. Koski R, Kennedy KK. Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria. Ann Allergy Asthma Immunol. 2017;119(5):397–401.

    Article  PubMed  Google Scholar 

  23. Adhya Z, Karim Y. Doxepin may be a useful pharmacotherapeutic agent in chronic urticaria. Clin Exp Allergy. 2015;45(8):1370.

    Article  CAS  PubMed  Google Scholar 

  24. Morgan M, Cooke A, Rogers L, Adams-Huet B, Khan DA. Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria. J Allergy Clin Immunol Pract. 2014;2(5):601–6.

    Article  PubMed  PubMed Central  Google Scholar 

  25. McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol. 2006;142(10):1337–42.

    Article  CAS  PubMed  Google Scholar 

  26. Zimmerman AB, Berger EM, Elmariah SB, Soter NA. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. J Am Acad Dermatol. 2012;66(5):767–70.

    Article  CAS  PubMed  Google Scholar 

  27. Bulkhi A, Cooke AJ, Casale TB. Biologics in chronic urticaria. Immunol Allergy Clin North Am. 2017;37(1):95–112.

    Article  PubMed  Google Scholar 

  28. Morgado-Carrasco D, Fusta-Novell X, Podlipnik S, Combalia A, Aguilera P. Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature. Photodermatol Photoimmunol Photomed. 2018;34(3):194–9.

    Article  PubMed  Google Scholar 

  29. Goetze S, Elsner P. Solar urticaria. J Dtsch Dermatol Ges. 2015;13(12):1250–3.

    PubMed  Google Scholar 

  30. Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. Elsevier; 2018.

    Google Scholar 

  31. Neill BC, Neill JA, Brauker J, Rajpara A, Aires DJ. Post-exposure prevention of toxicodendron dermatitis with early forceful unidirectional washing. J Am Acad Dermatol. 2018.

    Google Scholar 

  32. Paek SY, Lim HW. Chronic actinic dermatitis. Dermatol Clin. 2014;32(3):355–61. viii–ix.

    Article  CAS  PubMed  Google Scholar 

  33. Scheinfeld N. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa. Dermatol Online J. 2014;20(5):22692.

    Article  PubMed  Google Scholar 

  34. Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobata with oral zinc. Br J Dermatol. 1999;141(6):1137–8.

    Article  CAS  PubMed  Google Scholar 

  35. Kim WB, Shelley AJ, Novice K, Joo J, Lim HW, Glassman SJ. Drug-induced phototoxicity: a systematic review. J Am Acad Dermatol. 2018;79(6):1069–75.

    Article  CAS  PubMed  Google Scholar 

  36. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 2002;25(5):345–72.

    Article  CAS  PubMed  Google Scholar 

  37. Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol. 2016;75(3):467–79.

    Article  PubMed  Google Scholar 

  38. Escobar-Morreale HF, Carmina E, Dewailly D, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18(2):146–70.

    Article  CAS  PubMed  Google Scholar 

  39. van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database Syst Rev. 2015;(4):CD010334.

    Google Scholar 

  40. de Almeida AR, Montagner S. Botulinum toxin for axillary hyperhidrosis. Dermatol Clin. 2014;32(4):495–504.

    Article  PubMed  CAS  Google Scholar 

  41. Cruddas L, Baker DM. Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review. J Eur Acad Dermatol Venereol. 2017;31(6):952–63.

    Article  CAS  PubMed  Google Scholar 

  42. Pariser DM, Ballard A. Topical therapies in hyperhidrosis care. Dermatol Clin. 2014;32(4):485–90.

    Article  CAS  PubMed  Google Scholar 

  43. Hwang S, Schwartz RA. Keratosis pilaris: a common follicular hyperkeratosis. Cutis. 2008;82(3):177–80.

    PubMed  Google Scholar 

  44. Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016;308(8):539–51.

    Article  PubMed  Google Scholar 

  45. Sharma A, Bialynicki-Birula R, Schwartz RA, Janniger CK. Lichen planus: an update and review. Cutis. 2012;90(1):17–23.

    PubMed  Google Scholar 

  46. Kern JS, Technau-Hafsi K, Schwacha H, et al. Esophageal involvement is frequent in lichen planus: study in 32 patients with suggestion of clinicopathologic diagnostic criteria and therapeutic implications. Eur J Gastroenterol Hepatol. 2016;28(12):1374–82.

    Article  CAS  PubMed  Google Scholar 

  47. Sartori-Valinotti JC, Bruce AJ, Krotova Khan Y, Beatty CW. A 10-year review of otic lichen planus: the Mayo Clinic experience. JAMA Dermatol. 2013;149(9):1082–6.

    Article  PubMed  Google Scholar 

  48. Guenther LC, Kunynetz R, Lynde CW, et al. Acitretin use in dermatology. J Cutan Med Surg. 2017;21(3_suppl):2S–12S.

    Article  PubMed  Google Scholar 

  49. Lajevardi V, Ghodsi SZ, Hallaji Z, Shafiei Z, Aghazadeh N, Akbari Z. Treatment of erosive oral lichen planus with methotrexate. J Dtsch Dermatol Ges. 2016;14(3):286–93.

    PubMed  Google Scholar 

  50. Khandpur S, Sugandhan S, Sharma VK. Pulsed itraconazole therapy in eruptive lichen planus. J Eur Acad Dermatol Venereol. 2009;23(1):98–101.

    Article  CAS  PubMed  Google Scholar 

  51. Hollo P, Szakonyi J, Kiss D, Jokai H, Horvath A, Karpati S. Successful treatment of lichen planus with adalimumab. Acta Derm Venereol. 2012;92(4):385–6.

    Article  CAS  PubMed  Google Scholar 

  52. Deen K, McMeniman E. Mycophenolate mofetil in erosive genital lichen planus: a case and review of the literature. J Dermatol. 2015;42(3):311–4.

    Article  PubMed  Google Scholar 

  53. Murphy R. Lichen sclerosus. Dermatol Clin. 2010;28(4):707–15.

    Article  CAS  PubMed  Google Scholar 

  54. Howard M, Sahhar L, Andrews F, Bergman R, Gin D. Notalgia paresthetica: a review for dermatologists. Int J Dermatol. 2018;57(4):388–92.

    Article  PubMed  Google Scholar 

  55. Yeo B, Tey HL. Effective treatment of notalgia paresthetica with amitriptyline. J Dermatol. 2013;40(6):505–6.

    Article  PubMed  Google Scholar 

  56. Lee GL, Zirwas MJ. Granulomatous rosacea and periorificial dermatitis: controversies and review of management and treatment. Dermatol Clin. 2015;33(3):447–55.

    Article  CAS  PubMed  Google Scholar 

  57. Gruber-Wackernagel A, Byrne SN, Wolf P. Polymorphous light eruption: clinic aspects and pathogenesis. Dermatol Clin. 2014;32(3):315–34. viii.

    Article  CAS  PubMed  Google Scholar 

  58. Epstein JH. Polymorphous light eruptions: phototest technique studies. Arch Dermatol. 1962;85:502–4.

    Article  CAS  PubMed  Google Scholar 

  59. Tanew A, Radakovic S, Gonzalez S, Venturini M, Calzavara-Pinton P. Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of polymorphic light eruption. J Am Acad Dermatol. 2012;66(1):58–62.

    Article  PubMed  Google Scholar 

  60. Marini A, Jaenicke T, Grether-Beck S, et al. Prevention of polymorphic light eruption by oral administration of a nutritional supplement containing lycopene, beta-carotene, and Lactobacillus johnsonii: results from a randomized, placebo-controlled, double-blinded study. Photodermatol Photoimmunol Photomed. 2014;30(4):189–94.

    Article  CAS  PubMed  Google Scholar 

  61. Steinhoff M, Cevikbas F, Ikoma A, Berger TG. Pruritus: management algorithms and experimental therapies. Semin Cutan Med Surg. 2011;30(2):127–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Ekelem C, Juhasz M, Khera P, Mesinkovska NA. Utility of naltrexone treatment for chronic inflammatory dermatologic conditions: a systematic review. JAMA Dermatol. 2018.

    Google Scholar 

  63. Tandon P, Rowe BH, Vandermeer B, Bain VG. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol. 2007;102(7):1528–36.

    Article  CAS  PubMed  Google Scholar 

  64. Dull MM, Kremer AE. Management of chronic hepatic itch. Dermatol Clin. 2018;36(3):293–300.

    Article  PubMed  CAS  Google Scholar 

  65. Handler NS, Handler MZ, Stephany MP, Handler GA, Schwartz RA. Porphyria cutanea tarda: an intriguing genetic disease and marker. Int J Dermatol. 2017;56(6):e106–17.

    Article  PubMed  Google Scholar 

  66. Green JJ, Manders SM. Pseudoporphyria. J Am Acad Dermatol. 2001;44(1):100–8.

    Article  CAS  PubMed  Google Scholar 

  67. Massone C, Ambros-Rudolph CM, Di Stefani A, Mullegger RR. Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis. Acta Derm Venereol. 2006;86(6):538–40.

    Article  PubMed  Google Scholar 

  68. Cooke NS, McKenna K. A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine. Clin Exp Dermatol. 2007;32(1):64–6.

    CAS  PubMed  Google Scholar 

  69. Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148–55.

    Article  PubMed  Google Scholar 

  70. Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):465–71.

    Article  CAS  PubMed  Google Scholar 

  71. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol. 2012;66(5):699. e691–618. quiz 717-698.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Henry Ford Health System, 3031 West Grand Blvd, Suite 800, Detroit, MI, 48202, USA

    Samantha L. Schneider & Holly Kerr

Authors
  1. Samantha L. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Holly Kerr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Holly Kerr .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Henry W. Lim

  2. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Laurie L. Kohen

  3. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Samantha L. Schneider

  4. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Danielle Yeager

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schneider, S.L., Kerr, H. (2020). General Dermatology. In: Lim, H., Kohen, L., Schneider, S., Yeager, D. (eds) Practical Guide to Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-18015-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18015-7_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18014-0

  • Online ISBN: 978-3-030-18015-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation